Ascendis Pharma A (ASND) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ascendis Pharma A  (NASDAQ: ASND)


Ascendis Pharma A's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Ascendis Pharma A's ROA in the fourth quarter of 2025?
Ascendis Pharma A recorded a cumulative net loss of $-258 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -17.67%.

However, within the Healthcare sector 395 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4502.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change 11.94 % 6.2 % 11.94 % 11.94 % 42.7 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -258 -255 -293 -366 -409
Return On Assets (TTM) -17.67 % -17.96 % -20.93 % -26.95 % -30.97 %
ASND's Total Ranking # 4502 # # # # 5108
Total Assets (TTM) in million 1,459 1,459 1,459 1,459 1,303
Seq. Total Assets Change 0 % 0 % 0 % 11.94 % -5.13 %
Seq. Net Income Change - - - - -

ASND's 5 Years Annual ROA >> Back to ASND Management Effectiveness >> Compare ASND ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 146
Sector # 396
Overall # 4068

Return On Assets Statistics
High Average Low
-17.51 %
-38.9 %
-57.02 %
(Dec 31 2025)   (Dec 31 2023)





Financial Statements
Ascendis Pharma A's Assets $ 1,459 million ASND's Balance sheet
Ascendis Pharma A's Income $ -43 million Quarterly ASND's Income Statement
ASND's Income by Division See ASND's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 8.21 % 42.7 % -25.17 % 0.44 % 10.73 %
Total Assets in million 1,410 1,303 913 1,221 1,215
Y / Y Net Income Change - - - - -
Net Income in million -255 -423 -521 -653 -430
Annual Return On Assets -18.11 % -32.49 % -57.02 % -53.52 % -35.36 %

ASND's 5 Years Annual ROA >> Back to ASND Management Effectiveness >> Compare ASND ROA to its Competitors



More Return On Assets Ratios
ASND's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ASND's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ASND's Competitors
Subscribers only: Roa for Ascendis Pharma A's Suppliers
Subscribers only: Return On Assets for ASND's Customers

You may also want to know
ASND's Roi ASND's Inventory Turnover Ratio ASND's Growth Rates ASND's Dividend Comparisons
ASND's Profitability Ratios ASND's Asset Turnover Ratio ASND's Dividend Growth
ASND's Roe ASND's Valuation Ratios ASND's Financial Strength Ratios ASND's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA

Date modified: 2026-09-18T14:10:37+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.